178 related articles for article (PubMed ID: 20184766)
1. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
[TBL] [Abstract][Full Text] [Related]
2. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
Benoit AC; Younger J; Beaver K; Jackson R; Loutfy M; Masching R; Nobis T; Nowgesic E; O'Brien-Teengs D; Whitebird W; Zoccole A; Hull M; Jaworsky D; Rachlis A; Rourke S; Burchell AN; Cooper C; Hogg R; Klein MB; Machouf N; Montaner J; Tsoukas C; Raboud J; ;
Antivir Ther; 2017; 22(4):325-335. PubMed ID: 27925609
[TBL] [Abstract][Full Text] [Related]
3. Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy.
Romih V; Zidovec Lepej S; Gedike K; Lukas D; Begovac J
PLoS One; 2010 Nov; 5(11):e15051. PubMed ID: 21124844
[TBL] [Abstract][Full Text] [Related]
4. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
[TBL] [Abstract][Full Text] [Related]
5. High retention in HIV care at a tertiary care centre in Toronto, Canada.
Szadkowski L; Walmsley S; Burchell AN; Collins E; Rourke SB; Raboud J;
AIDS Care; 2018 Feb; 30(2):246-254. PubMed ID: 28678619
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns.
Laine C; Zhang D; Hauck WW; Turner BJ
J Acquir Immune Defic Syndr; 2002 Mar; 29(3):270-4. PubMed ID: 11873076
[TBL] [Abstract][Full Text] [Related]
7. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
[TBL] [Abstract][Full Text] [Related]
8. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
[TBL] [Abstract][Full Text] [Related]
9. Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.
d'Arminio Monforte A; Gianotti N; Cozzi-Lepri A; Pinnetti C; Andreoni M; di Perri G; Galli M; Poli A; Costantini A; Orofino G; Maggiolo F; Mazzarello G; Celesia BM; Luciani F; Lazzarin A; Sighinolfi L; Rizzardini G; Bonfanti P; Perno CF; Antinori A;
Antivir Ther; 2014; 19(3):319-24. PubMed ID: 24036891
[TBL] [Abstract][Full Text] [Related]
10. Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.
King E; Kinvig K; Steif J; Qiu AQ; Maan EJ; Albert AY; Pick N; Alimenti A; Kestler MH; Money DM; Lester RT; Murray MCM
J Med Internet Res; 2017 Jun; 19(6):e190. PubMed ID: 28572079
[TBL] [Abstract][Full Text] [Related]
11. Nonfinancial factors associated with decreased plasma viral load testing in Ontario, Canada.
Raboud JM; Abdurrahman ZB; Major C; Millson P; Robinson G; Rachlis A; Bayoumi AM
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):327-32. PubMed ID: 15980694
[TBL] [Abstract][Full Text] [Related]
12. Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
Dragovic G; Smith CJ; Jevtovic D; Dimitrijevic B; Kusic J; Youle M; Johnson MA
BMC Infect Dis; 2016 Mar; 16():106. PubMed ID: 26939611
[TBL] [Abstract][Full Text] [Related]
13. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
[TBL] [Abstract][Full Text] [Related]
14. A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.
Gillis J; Loutfy M; Bayoumi AM; Antoniou T; Burchell AN; Walmsley S; Cooper C; Klein MB; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Hogg R; Raboud J;
J Acquir Immune Defic Syndr; 2016 Dec; 73(5):531-539. PubMed ID: 27851713
[TBL] [Abstract][Full Text] [Related]
15. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
[TBL] [Abstract][Full Text] [Related]
16. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
Samji H; Taha TE; Moore D; Burchell AN; Cescon A; Cooper C; Raboud JM; Klein MB; Loutfy MR; Machouf N; Tsoukas CM; Montaner JS; Hogg RS;
HIV Med; 2015 Feb; 16(2):76-87. PubMed ID: 25174373
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study.
Cescon A; Patterson S; Chan K; Palmer AK; Margolese S; Burchell AN; Cooper C; Klein MB; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Raboud JM; Loutfy MR;
PLoS One; 2013; 8(12):e83649. PubMed ID: 24391803
[TBL] [Abstract][Full Text] [Related]
18. Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study.
Carter A; de Pokomandy A; Loutfy M; Ding E; Sereda P; Webster K; Nicholson V; Beaver K; Hogg RS; Kaida A;
BMC Res Notes; 2017 Mar; 10(1):138. PubMed ID: 28340606
[TBL] [Abstract][Full Text] [Related]
19. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
20. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
